Rationale for Poly(ADP-ribose) Polymerase (PARP) Inhibitors in Combination Therapy with Camptothecins or Temozolomide Based on PARP Trapping versus Catalytic Inhibition

We recently showed that poly(ADP-ribose) polymerase (PARP) inhibitors exert their cytotoxicity primarily by trapping PARP-DNA complexes in addition to their NAD(+)-competitive catalytic inhibitory mechanism. PARP trapping is drug-specific, with olaparib exhibiting a greater ability than veliparib, w...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Murai, Junko, Zhang, Yiping, Morris, Joel, Ji, Jiuping, Takeda, Shunichi, Doroshow, James H., Pommier, Yves
Formato: Artigo
Idioma:Inglês
Publicado em: The American Society for Pharmacology and Experimental Therapeutics 2014
Assuntos:
Chemotherapy, Antibiotics, and Gene Therapy
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4019318/
https://ncbi.nlm.nih.gov/pubmed/24650937
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/jpet.113.210146
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados